Creation of an electronic patient-reported outcome measure platform Voxe: a mixed methods study protocol in

Samantha J Anthony1,2,3, Sarah J Pol4, Jia Lin4

  • 1Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada samantha.anthony@sickkids.ca.

BMJ Open
|October 20, 2021
PubMed

Insights

This study developed Voxe, a user-centered electronic platform for patient-reported outcome measures (PROMs) to improve care for pediatric transplant patients. Voxe engages patients and providers in design and testing for better health outcomes.

Area of Science:

  • Pediatric Health
  • Health Informatics
  • Patient Engagement

Background:

  • Patient-reported outcome measures (PROMs) are crucial for engaging patients and informing shared decision-making in clinical settings.
  • Implementing PROMs in pediatric solid organ transplant care can significantly improve patient outcomes.
  • Existing PROM platforms may not adequately address the specific needs of pediatric populations.

Purpose of the Study:

  • To create Voxe, a user-centered electronic platform for collecting PROMs in pediatric solid organ transplant recipients.
  • To enhance patient engagement and shared decision-making through the implementation of a novel PROM platform.
  • To improve health outcomes for pediatric solid organ transplant patients by integrating PROMs into routine clinical care.

Main Methods:

  • A user-centered design approach was employed, involving iterative testing with pediatric transplant recipients (ages 8-17) and healthcare providers.
  • Two phases included user interface design with task-based activities and usability testing using the think-aloud technique.
  • Data collection involved questionnaires, semi-structured interviews, and task performance metrics (e.g., efficiency, satisfaction, error rates).

Main Results:

  • Iterative design and testing phases engaged patients and providers to refine the Voxe platform's usability and functionality.
  • The study successfully generated a user-centered electronic PROM platform tailored for pediatric transplant recipients.
  • Methodological and operational insights were gained to inform future implementation strategies.

Conclusions:

  • Voxe represents a significant advancement in utilizing electronic PROMs for pediatric solid organ transplant care.
  • The user-centered design ensures the platform meets the needs of young patients and healthcare providers.
  • Successful implementation of Voxe has the potential to improve patient engagement and health outcomes in this vulnerable population.
Abstract

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
594
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
80
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
34
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
563
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
33
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
28